Literature DB >> 4119542

The interaction of normal lymphocytes nd cells from lymphoid cell lines. 3. Studies on activation in an autochthonous system.

C M Steel, D A Hardy, N R Ling, H M Dick, P Mackintosh, W B Crichton.   

Abstract

Mesh:

Substances:

Year:  1973        PMID: 4119542      PMCID: PMC1422866     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  25 in total

Review 1.  Antigens of virus-induced tumors.

Authors:  K Habel
Journal:  Adv Immunol       Date:  1969       Impact factor: 3.543

2.  Altered antigenicity of cultured mononucleosis lymphocytes.

Authors:  U Junge; J Hoekstra; F Deinhardt
Journal:  Lancet       Date:  1970-07-25       Impact factor: 79.321

3.  HL-A identical phenotypes and genotypes in unrelated individuals.

Authors:  J J van Rood; V P Eijsvoogel
Journal:  Lancet       Date:  1970-04-04       Impact factor: 79.321

4.  Evidence of altered antigenicity in cultured lymphoid cells from patients with infectious mononucleosis.

Authors:  C M Steel; D A Hardy
Journal:  Lancet       Date:  1970-06-20       Impact factor: 79.321

5.  HL-A antigens of human lymphoid cells in long-term tissue culture.

Authors:  G N Rogentine; P Gerber
Journal:  Transplantation       Date:  1969-07       Impact factor: 4.939

6.  Lymphocyte transformation in vitro. II. Mixed lymphocyte culture in relation to leucocyte antigens.

Authors:  P T Schellekens; B Vriesendorp; V P Eijsvoogel; A Van Leeuwen; J J Van Rood; V Miggiano; R Ceppellini
Journal:  Clin Exp Immunol       Date:  1970-02       Impact factor: 4.330

7.  A certain symmetry: histocompatibility antigens compared with immunocyte receptors.

Authors:  F M Burnet
Journal:  Nature       Date:  1970-04-11       Impact factor: 49.962

8.  Effects of some cellular antigens on lymphocytes and the nature of the mixed lymphocyte reaction.

Authors:  D A Hardy; N R Ling
Journal:  Nature       Date:  1969-02-08       Impact factor: 49.962

9.  Exceptional lymphocyte stimulating capacity of cells from lymphoid cell lines.

Authors:  D A Hardy; N R Ling; S C Knight
Journal:  Nature       Date:  1969-08-02       Impact factor: 49.962

10.  Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity.

Authors:  D B Amos; F H Bach
Journal:  J Exp Med       Date:  1968-10-01       Impact factor: 14.307

View more
  7 in total

1.  Nodular lymphoid hyperplasia of the bowel in primary hypogammaglobulinaemia: study of in vivo and in vitro lymphocyte function.

Authors:  A D Webster; S Kenwright; J Ballard; M Shiner; G Slavin; A J Levi; G Loewi; G L Asherson
Journal:  Gut       Date:  1977-05       Impact factor: 23.059

2.  Antigen differences, detected by indirect immunofluorescence, between human peripheral and thoracic duct lymphocytes, and human cultured lymphoblasts.

Authors:  D Thomas; D C Edwards
Journal:  Clin Exp Immunol       Date:  1973-12       Impact factor: 4.330

3.  Control mechanisms in infectious mononucleosis.

Authors:  A M Denman; B K Pelton
Journal:  Clin Exp Immunol       Date:  1974-09       Impact factor: 4.330

4.  The interaction of normal lymphocytes and cells from lymphoid cell lines. VI. Line-directed cytotoxic specificity of lymphocytes activated by autochthonous or allogeneic LCL cells.

Authors:  C M Steel; D A Hardy; N R Ling; I J Lauder
Journal:  Immunology       Date:  1974-05       Impact factor: 7.397

5.  Suppression of mixed lymphocyte reactions by pregnancy serum.

Authors:  J G Bissenden; N R Ling; P Mackintosh
Journal:  Clin Exp Immunol       Date:  1980-01       Impact factor: 4.330

6.  Stimulation of syngeneic and allogeneic lymphoid cells by tumour cells in vitro.

Authors:  M R Potter; B M Balfour
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

7.  Response of remission lymphocytes to autochthonous leukaemic myeloblasts.

Authors:  G M Taylor; C B Freeman; R Harris
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.